[New Times] With the introduction of Dihydroartemisinin-piperaquine (DHAP) and artesunate-pyronaridine (ASPY) on the list of anti-malarial drugs available in Rwanda, the number of treatments that can be transcribed for patients in the country has increased tremendously.
Source link : https://allafrica.com/stories/202501130184.html
Author :
Publish date : 2025-01-13 09:43:48
Copyright for syndicated content belongs to the linked Source.